Good MorningEquity markets pulled back again on Wednesday after the FOMC minutes revealed more risks than previously feared, and the minutes cited tight labor markets and higher-than-acceptable wage inflation, among other risks to inflation. The risks could lead to additional rate hikes not priced into equities. This sets up a situation in which the FOMC outlook darkens and puts additional weight on the market. In this scenario, the top reached by the S&P 500 is the highest level investors will see until later this year or next.
The risk is centered on the FOMC again, but the driver of that risk is oil. Oil prices retreated this week but remain uptrending and are on the verge of breaking out to new highs. The market is tilted in favor of higher prices, although the data has some volatility. The odds are high that oil prices will continue to trend higher through the end of the year and lift consumer-level inflation along with it. Featured: The DOJ Just Paved the Way for Account Seizures (Ad) 
|
Markets | | | Asian shares have slipped as rising yields in the bond market on Wall Street set off expectations that high interest rates would continue in the U.S. Benchmarks fell in Tokyo, Hong Kong, Shanghai and Seoul, while rising slightly in Sydney Read the Full Story |
|
From Our PartnersBehind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented.
And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots…
What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book. | | | Claim your FREE copy of Crypto Revolution now. |
|
Stocks | | |
Tickets. Flights. A new 72” TV. A retro jersey for your favorite player.
With just a few weeks before the National Football League (NFL) season kicks off, preparations are well underway for football fans. For some, formulating a fantasy football strategy won’t be the only resear... Read the Full Story |
|
Stocks | | |
You could think of Vita Coco Co.'s (NASDAQ: COCO) coconut water as a beach vacation in a box.
The company, which went public in October 2021, markets its coconut water in several flavors, and also sells coconut milk and coconut juice.
Its other brands include Runa, a plant-based ener... Read the Full Story |
|
From Our PartnersWith the next presidential cycle heating up and Trump leading the charge, major market shifts are already taking shape.
For investors who position early, the opportunities could be significant.
That’s why we’ve just released a brand-new report:
📈 “5 Best Stocks to Buy Under Trump’s Presidency.” | | | Get the full report here—and stay ahead of the curve. |
|
Markets | | |
There is 1 thing clear in The TJX Companies (NYSE: TJX) Q2 results, and that it is hitting its stride. The off-price retailers were expected to benefit from shifting consumer habits, and they are. It took a little longer than the market first anticipated, but the signs are clear that full-price re... Read the Full Story |
|
Stocks | | |
Outdoor recreation got a big boost during the pandemic as social distancing and lockdowns caused people to seek out other forms of leisure and entertainment that didn't involve human interactions.
Recreational vehicle (RV) sales skyrocketed, as evidenced by the jump in business for RV makers like... Read the Full Story |
|
|
Markets | | | Russia's ruble has fallen a long way in recent months, and the country’s central bank has stepped in to try to halt the slide. Until now, the government stood aside as the declining ruble helped its budget. But a weaker currency also poses the threat of higher prices for everyday people in Russia — ... Read the Full Story |
|
Markets | | | Russia’s central bank made a big interest rate hike Tuesday, an emergency move designed to fight inflation and strengthen the ruble after the country's currency reached its lowest value since early in the war with Ukraine.The ruble has lost more than a third of its value since the beginning of the y... Read the Full Story |
|
Markets | | | Coinbase said it's received regulatory approval to bring federally regulated crypto futures trading to eligible customers in the U.S., sending shares sharply higher before the opening bell Wednesday. In June, the U.S. Securities and Exchange Commission filed lawsuits against Binance and Coinbase, sa... Read the Full Story |
|
Markets | | | UBS will pay U.S. authorities $1.44 billion to settle the last lingering legal case over Wall Street’s role in the housing bubble of the early 2000s, which ultimately led to the 2008 financial crisis and Great Recession Read the Full Story |
|
Markets | | |
Target (NYSE: TGT) shares surged about 10% after the Q2 earnings report was released but don’t read too much into the news. The surge is a knee-jerk reaction to a mixed report that does nothing to improve the outlook. If anything, the Q2 strengths are 1-offs that won’t persist in the f... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients; and ATRC-501/MAM01, that targets the circumsporozoite protein of Plasmodium falciparum for the treatment of malaria. Its products in pre-clinical stage include APN-497444, an antibody drug conjugate (ADC) against a novel tumor glycan target; and APN-346958, a CD3 bispecific T-cell engager against an RNA-binding protein target. It has a collaboration and license agreement with Xencor, Inc. for research, development, and commercialization of novel CD3 bispecific antibodies in oncology; licensing agreement with the Bill & Melinda Gates Medical Research Institute for the development and commercialization of MAM01/ATRC-501 for the prevention of malaria. The company was incorporated in 2010 and is based in San Carlos, California. | | View Today's Stock Pick |
|
